The Latin America, Middle East and Africa Biosurgery Market would witness market growth of 7.4% CAGR during the forecast period (2019-2025).
Biological products can be used in several applications in orthopedic surgeries. Postoperative blood loss is a crucial issue that leads to a high rate of mortality. In order to prevent excessive blood loss at the time of hip and knee arthroplasty, hemostatic agents like intravenous tranexamic acid are used. The biosurgery market has been projected to benefit from enormous latent opportunities in an increased number of surgeries across the world. A wide range of surgeries is meant to treat sports-related and severe trauma injuries. The market is also expected to bring in significant gains from the rapidly aging population in the emerging countries.
Biosurgery applications are used to treat a wide range of ailments. Neurosurgery and spine surgery treats diseases concerned with the nervous system. It includes the spinal cord, brain, peripheral nervous system, as well as extra-cranial cerebrovascular system. Cardiovascular and thoracic surgical treatments can be conducted for diseases that are associated with coronary arteries, heart, major blood vessels, lungs, chest, and esophagus.
The Latin America Bio Surgery market’s main driver is the increased approval by regulatory authorities of biosurgery products. Furthermore, the rising number of surgeries, increasing geriatric populations, changes in lifestyle and increasing need for effective management of blood loss, supports the region’s market growth. However, there are little-to-no reimbursements for products of biosurgery and the associated costs are usually too high to be used by the general public. This in general, together with the rising costs of surgical procedures, acts as market restrictions.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
• General Surgeries
• Orthopedic Surgeries
• Neurological Surgeries
• Cardiovascular Surgeries
• Other Applications
• Surgical Sealants
• Soft Tissue Attachments
• Adhesion Barriers
• Hemostatic Agents
• Bone Graft Substitutes
• Other Products
• Saudi Arabia
• South Africa
• Rest of LAMEA
• Baxter International, Inc.
• Johnson and Johnson
• Medtronic PLC
• Pfizer, Inc.
• Stryker Corporation
• B. Braun Melsungen AG
• Sanofi S.A.
• Becton, Dickinson and Company
• Integra LifeSciences Holdings Corporation
• CSL Limited
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed...
Market Introduction Infertility is defined as not being able to get pregnant or conceive.It can be primary infertility (refers to couples who cannot become pregnant after at least 1 year having sex without using birth control methods) and secondary infertility (refers to couples who cannot get pregnant more than once). There are...
The Asia Pacific Surgical Robotic Systems Market would witness market growth of 22.8% CAGR during the forecast period (2020-2026). Key components ascribing to the development includes expanding adoption of minimally invasive surgeries among patients due to its additional advantages, for example, the requirement for shorter stays in...
The Latin America, Middle East and Africa Antibacterial Glass Market would witness market growth of 11% CAGR during the forecast period (2020-2026). The outbreak of COVID-19 has a big impact on the economy as many non-essential businesses got temporarily closed from the first quarter of 2020. In the future to fight with similar kinds...
The Vein Illuminator Market is recording a CAGR of 24.6%, over the forecast period (2019 - 2024). Hospitals are the major. Hospitals have been the prime beneficiaries of such products, owing to the ease of performing blood draw activities because of this product, the demand is increasing and driving the...
Summary Summa Health System (Summa) is a healthcare service provider that offers medical services through its integrated healthcare delivery system. The center offers services including bariatric care, cardiovascular, neurology, weight loss, mental health, orthopedic, internal medicine, cancer and oncology, general medicine and...
Summary Detroit Medical Center (DMC) is a healthcare service provider, which offers services in the areas of clinical care, healthcare research and medical education. It operates one of the leading hospitals in Detroit and is one of the largest health care providers in Southeast Michigan. The organization offers services related...
Summary Mount Sinai Medical Center (Mount Sinai) is a healthcare service provider that offers neuroscience, cardiology, oncology and orthopedic solutions. The hospital offers services such as adult congenital heart disease clinic, aortic surgery, cardiac anesthesia, cardiac catheterization, cardiac rehabilitation, cardiac surgery,...
Summary Henry Ford Health System (HFHS) is a not for profit health care services provider which offers acute, primary, tertiary, quaternary and preventive care services. The organization offers its services in the areas of cardiology, cardiovascular surgery, neurology and neurosurgery, orthopedics, sports medicine, multi-organ...
Summary Rex Healthcare (Rex) is a healthcare service provider that offers acute care and wellness services. The hospital’s services comprise blood services, diagnostic services, home services, laboratory services, long-term care, mammography services, nursing, occupational health services, pharmacy services, primary care, radiology...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.